Cuomo Alessandro

Breve curriculum vitae
EDUCATION AND TRAINING
 
2000-2005 Liceo Classico Dante Alighieri  MaturitàClassica Literature Philosophy Science
2006-2012 University of Siena School of Medicine Doctor in Medicine and Surgery (M.D.) Medicine
2014-2018 Department of Psychiatry, University of Siena School of Medicine, Siena, Italy Diplomate, Italian Board of Psychiatrists Psychiatry
2017-current University of Siena, Molecular Medicine PhD Program, Siena, Italy Ongoing Pharmacological Treatment of Mental Illness During Pregnancy and Lactation
2018-current Medical Doctor at Carlo Poma Mantova, ASST Region Lombardy Healthcare System Ongoing General Hospital Psychiatry
 
 
CERTIFICATION AND LICENSURES, MEDICAL OR OTHER PROFESSIONAL LICENSURES:
 
• Diplomate, Italian National Board of Medical Examiners Licensure Unrestricted License to practice Medicine and Surgery (2012- present)
• Dregree in Medicine and Surgery (2012) final grade 110/110 
• Medical Elective Program at King’s College (Institute of psychiatry, psychology & Neuroscience) associate with Clinical assessments at The National Affective Disorders Clinic at The Maudsley Hospital and at OPTIMA Mood     Disorders Service at Lambeth Hospital (2017)  
• Certificato ICF (International classification of functioning, disability and health) (2017)        
• Investigator Site Personnel ICH GCP Training Certificate, Version 1, April 2014. Completed Good Clinical Practice training that meets the Minimum Criteria for ICH E6 GCP Investigator Site Personnel Training identified by       TransCelerate BioPharma, Inc. (includes additional requirements for medical device studies as specified by ISO 14155). (2017)
• Investigator Safety Training, Version 3, 15 July 2015. Successfully completed the course in (2017)
• Diploma, Corso di perfezionamento 2018 in revisioni sistematiche e metanalisi per la produzione di linee guida evidence-based  in ambito sanitario - Polo Universitario Santa Marta Via Cantarane, 24 Verona (2018)
 Diplomate, University of Siena General Psychiatry Residency Training Program; Siena, Italy: (2018)  highest grades  (70/70) and honors 
 
 
Pubblicazioni e abstracts
 PUBLICATIONS
 
 Referred Articles (ENG):
 
1.Fagiolini A, Forgione RN, Morana B, Maccari M, Goracci A, Bossini L, Pellegrini F, Cuomo A, Casamassima F. Asenapine for the treatment of manic and mixed episodes associated with bipolar I disorder: from clinical research to clinical practice. 
a.Expert Opin Pharmacother. 2013 Mar;14(4):489-504. doi: 10.1517/14656566.2013.765859. Epub 2013 Jan 29.
2.Fagiolini A, Forgione R, Maccari M, Cuomo A, Morana B, Dell'Osso MC, Pellegrini F, Rossi A. Prevalence, chronicity, burden and borders of bipolar disorder.  
a.J Affect Disord. 2013 Jun;148(2-3):161-9. doi: 10.1016/j.jad.2013.02.001. Epub 2013 Mar 7.
3.Fagiolini A, Coluccia A, Maina G, Forgione RN, Goracci A, Cuomo A, Young AH. Diagnosis, Epidemiology and Management of Mixed States in Bipolar Disorder. 
a.CNS Drugs. 2015 Sep;29(9):725-40. doi: 10.1007/s40263-015-0275-6.
4.Goracci A, Forgione RN, De Giorgi R, Coluccia A, Cuomo A, Fagiolini A. Practical guidance for prescribing trazodone extended-release in major depression.
a.Expert Opin Pharmacother. 2016;17(3):433-41. doi: 10.1517/14656566.2016.1133587. Epub 2016 Jan 19.
5.Cuomo A, Nikolova VL, Yalin N, Arnone D, Fagiolini A, Young AH. Pharmacological treatment of mixed states. CNS Spectr. 2017 Apr; 22(2):186-195. doi: 10.1017/S1092852917000013. Epub 2017 Apr 18.
6.A. Cuomo, N. Giordano, A.Goracci , A. Fagiolini Depression and Vitamin D Deficiency: Causality, Assessment, and Clinical Practice Implications. 
a.Neuropsychiatry 07(05). January 2017.
7.Fagiolini A, Cuomo A. On the centrality of mixed features in mood disorders: Listening to Kraepelin and Weygandt and moving forward.
8.Bipolar Disord. 2017 Dec;19(8):704-705. doi: 10.1111/bdi.12537. Epub 2017 Aug 23.
9.Cuomo A, Goracci A, Fagiolini A. Aripiprazole use during pregnancy, peripartum and lactation. A systematic literature search and review to inform clinical practice.
a.J Affect Disord. 2018 Mar 1;228:229-237. doi: 10.1016/j.jad.2017.12.021. Epub 2017 Dec 14. 
10. Galderisi S, Rucci P, Kirkpatrick B, Mucci A, Gibertoni D, Rocca P, Rossi A, Bertolino A, Strauss GP, Aguglia E, Bellomo A, Murri MB, Bucci P, Carpiniello B, Comparelli A, Cuomo A, De Berardis D, Dell'Osso L, Di Fabio F, Gelao B, Marchesi C, Monteleone P, Montemagni C, Orsenigo G, Pacitti F, Roncone R, Santonastaso P, Siracusano A, Vignapiano A, Vita A, Zeppegno P, Maj M; Italian Network for Research on Psychoses. Interplay Among Psychopathologic Variables, Personal Resources, Context-Related Factors, and Real-life Functioning in Individuals With Schizophrenia: A Network Analysis. JAMA Psychiatry. 2018 Apr 1;75(4):396-404. doi: 10.1001/jamapsychiatry.2017.4607.
11. Pozza A, Lochner C, Ferretti F, Cuomo A, Coluccia A. Does higher severity really correlate with a worse quality of life in obsessive-compulsive disorder? A meta-regression. Neuropsychiatr Dis Treat. 2018 Apr 16;14:1013-1023. doi: 10.2147/NDT.S157125. eCollection 2018.
12. Rocca P, Galderisi S, Rossi A, Bertolino A, Rucci P, Gibertoni D, Montemagni C, Bellino S, Aguglia E, Amore M, Bellomo A, Biondi M, Carpiniello B, Cuomo A, D'Ambrosio E, dell'Osso L, Girardi P, Marchesi C, Monteleone P, Montemitro C, Oldani L, Pacitti F, Roncone R, Siracusano A, Tenconi E, Vita A, Zeppegno P, Steardo L Jr, Vignapiano A, Maj M; Italian Network for Research on Psychoses. Disorganization and real-world functioning in schizophrenia: Results from the multicenter study of the Italian Network for Research on Psychoses.Schizophr Res. 2018 Jun 10. pii: S0920-9964(18)30314-1. doi: 10.1016/j.schres.2018.06.003. [Epub ahead of print]
13. Bucci P, Galderisi S, Mucci A, Rossi A, Rocca P, Bertolino A, Aguglia E, Amore M, Andriola I, Bellomo A, Biondi M, Cuomo A, dell'Osso L, Favaro A, Gambi F, Giordano GM, Girardi P, Marchesi C, Monteleone P, Montemagni C, Niolu C, Oldani L, Pacitti F, Pinna F, Roncone R, Vita A, Zeppegno P, Maj M; Italian Network for Research on Psychoses. Premorbid academic and social functioning in patients with schizophrenia and its associations with negative symptoms and cognition. cta Psychiatr Scand. doi: 10.1111/acps.12938. [Epub ahead of print] 2018 Jul 8
14. Cuomo A, Maina G, Neal SM, De Montis G, Rosso G, Scheggi S, Beccarini Crescenzi B, Bolognesi S, Goracci A, Coluccia A, Ferretti F, Fagiolini A. Using sertraline in postpartum and breastfeeding: balancing risks and benefits.Expert Opin Drug Saf. 2018 Jul;17(7):719-725. doi: 10.1080/14740338.2018.1491546. Epub 2018 Jul 5.15.Cuomo A, Maina G, Rosso G, Beccarini Crescenzi B, Bolognesi S, Di Muro A, Giordano N, Goracci A, Neal SM, Nitti M, Pieraccini F, Fagiolini A. The microbiome: a new target for research and treatment of schizophrenia and its resistant presentations? A Systematic Literature Search and Review. Frontiers in Pharmacology – Neuropharmacology. 2018 Oct 15. doi: 10.3389/fphar.2018.01040.
16. Cuomo A, Maina G, Zanobini F, Rosso G, Ferretti F,  Baldini I, Santucci A, Fagiolini A Vitamin D Deficiency in a Sample of 290 Psychiatric Inpatients: Prevalence, Correlates, and Psychosocial Implications. Frontiers in Pharmacology – Neuropharmacology 7 Mar. 2019 doi: 10.3389/fpsyt.2019.00167
17. Ballerio M., Politi P., Crapanzano C., Emanuele E., Cuomo A., Goracci G., Fagiolini A. Clinical effectiveness of parenteral trazodone for the management of psychomotor activation in patients with bipolar disorder. 2018 Neuroendocrinology Letters 
18. Scheggi S., Pelliccia T., Cuomo A., De Montis M.G., Gambarana C. Antidepressant and pro-motivational effects of repeated lamotrigine treatment in a rat model of depressive symptoms; 2018. Heliyon Elsevier: Pharmaceutical Science, Psychiatry, Neuroscience.
19. Bauer R, Glenn T, Strejilevich S, Conell J, Alda M, Ardau R, Baune BT, Berk M, Bersudsky Y, Bilderbeck A, Bocchetta A, Castro AMP, Cheung EYW, Chillotti C, Choppin S, Cuomo A, Del Zompo M, Dias R, Dodd S, Duffy A, Etain B, Fagiolini A, Fernández Hernandez M, Garnham J, Geddes J, Gildebro J, Gitlin MJ, Gonzalez-Pinto A, Goodwin GM, Grof P, Harima H, Hassel S, Henry C, Hidalgo-Mazzei D, Lund AH, Kapur V, Kunigiri G, Lafer B, Larsen ER, Lewitzka U, Licht RW, Misiak B, Piotrowski P, Miranda-Scippa Â, Monteith S, Munoz R, Nakanotani T, Nielsen RE, O'Donovan C, Okamura Y, Osher Y, Reif A, Ritter P, Rybakowski JK, Sagduyu K, Sawchuk B, Schwartz E, Slaney C, Sulaiman AH, Suominen K, Suwalska A, Tam P, Tatebayashi Y, Tondo L, Veeh J, Vieta E, Vinberg M, Viswanath B, Zetin M, Whybrow PC, Bauer M. Int J Bipolar Disord. 2018 Sep; Internet use by older adults with bipolar disorder: international survey results.
20. Cuomo A., Bolognesi S., Goracci A., Ciuoli A., Beccarini Crescenzi B., Maina G., Rosso G, Facchi E., Maccora C., Giordano N., Verdino V., Fagiolini A. Feasibly, adherence and efficacy of liraglutide treatment in a sample of individuals with mood disorders and obesity Front. Psychiatry - Psychosomatic Medicine. Jan 2019.
21. Rosso G., Aragno E., Cuomo A., Fagiolini A., Di Salvo G., Maina G. Five-year follow-up of first-episode depression treated with psychodynamic psychotherapy or antidepressants. February 2019 Psychiatry Research DOI: 10.1016/j.psychres.2019.02.073
22. Cuomo A., Beccarini Crescenzi B, Goracci A, Bolognesi S, Giordano N, Rossi R, Facchi E, Neal SM, Fagiolini A. Drug safety evaluation of aripiprazole in bipolar disorder. Expert Opin Drug Saf. 2019 Jun;18(6):455-463. doi: 10.1080/14740338.2019.1617847. 
 
 
 Referred Articles (ITA):
 
1.Coluccia A, Nucci G, Cuomo A, Benvenuti M, Carabellese F, Fagiolini A, Gabbrielli M. Duties and liabilities for psychiatrists.  Riv Psichiatr. 2017 Nov-Dec;52(6):226-235. doi: 10.1708/2846.28726. [Article in Italian]
2.Turchi F, Cuomo A, Amodeo G, Favaretto E, Righini S, Mellina E, La Mela C, Fagiolini [The neural bases of social cognition in major depressive disorder: a review]. a.Riv Psichiatr. 2017 Jul-Aug;52(4):137-149. doi:10.1708/2737.27906. [Article in Italian]
3.Fagiolini A, Cuomo A.  Perphenazine, amitriptyline and perphenazine-amitriptyline: role in clinical practice. Societa italiana di psicopatologia in JOURNAL OF PSYCHOPATHOLOGY; 20, 1; 69-79; 
a.Società Italiana di Psicopatologia; 18 Congresso della Societa Italiana di Psicopatologia: La Psicopatologia e le età della vita: 18th Congress of the Italian Society of Psychopathology: the psychopathology and ages of life. Pacini Editore, S.p.A. , Pisa (Italy); 2014 [Article in Italian]
4.Folletti I, Gualtieri G, Dell'Omo M, Cuomo A, Coluccia A, Lancia M. Riflessioni medico-legali su un caso giudizario di mobbing. Riv Psichiatr. 2018 Sep-Oct;53(5):274-277. doi: 10.1708/3000.30007. [Article in Italian]
5.Cuomo A, Andrea Fagiolini  Divisione di Psichiatria, Dipartimento di Medicina Molecolare, Università di Siena Diagnosi e trattamento della depressione maggiore: strumenti valutativi e nuove opzioni terapeutiche per il medico di medicina generale Rivista Società Italiana di Medicina Generale 2018
6.Cuomo A, Andrea Fagiolini  Divisione di Psichiatria, Dipartimento di Medicina Molecolare, Università di Siena. Trattamento farmacologico antidepressivo in pazienti con malattie croniche o neoplasie maligne e nelle donne in gravidanza: vecchie e nuove opzioni terapeutiche. Rivista Società Italiana di Medicina Generale   2019
7.Cuomo A, Andrea Fagiolini  Divisione di Psichiatria, Dipartimento di Medicina Molecolare, Università di Siena. Disturbo Depressivo Maggiore e Sintomi Somatici. Diagnosi, Diagnosi Differenziale, Comorbilità e Principi di Trattamento 2019
8.Cuomo A.1,2, Fagiolini A1, Magnani PA2: 1. Dipartimento di Medicina Molecolare, Università di Siena, Divisione di Psichiatria; 2. S. C. Psichiatrica ASST Mantova 1 Carlo Poma. Effetti collaterali da antidepressivi nel trattamento della depressione maggiore 2019
 
 
 
 Book Chapters
 
- Alessandro Cuomo, Arianna Goracci, Andrea Fagiolini  Medication Associated Sexual Dysfunction in patients with Mental Illness. Part of the Trends in Andrology and Sexual Medicine book series (TASM). Springer International Publishing AG, part of Springer Nature 2018.
 
 Participation at conferences, courses, seminars

- “Drug-drug interactions in elderly population” Italian society of psychopathology (SOPSI) February 14th 2014, Turin.

- “Treatment of mental disorders in renal and liver failure” Italian society of psychopathology (SOPSI) February 2017, Rome

- “Strategies for the Prescription of Psychotropic Drugs” Long term treatment schizophrenic patients. Psichiatria Universitaria San Luigi Gonzaga 

   Orbassano (Turin), October 2017.

- “Prescribing Antipsychotics in Pregnancy and Lactation”: 12th National Italian Society of Social Psychiatry (SIPS) Congress. Napoli. 2017.

- “Trattamento dimensionale delle malattie mentali: Strategie di associazione dei farmaci psicotropi” Italian society of psychopathology (SOPSI) February 2018, Rome

- “Disturbi resistenti al trattamento: Depressione resistente” Italian society of psychopathology (SOPSI) February 2018, Rome

- “Trattamento della Depressione Durante la Gravidanza o in corso di Malattie Fisiche”. Evento è stato accreditato nell’ambito del programma nazionale di Educazione Continua in Medicina con l’obiettivo formativo tecnico-      professionale n. 18 contenuti (conoscenze e competenze) specifici di ciascuna professione, di ciascuna specializzazione e di ciascuna attività ultraspecialistica. Malattie rare. Sedi: Perugia; Presezzo, Milano, Trani. Anno        2018  

- “Tollerabilità degli antidepressivi e delle loro associazioni con altri farmaci” Medicina con l’obiettivo formativo tecnico-professionale n. 18 contenuti (conoscenze e competenze) specifici di ciascuna professione, di ciascuna specializzazione e di ciascuna attività ultraspecialistica. Malattie rare. Sede: Lamezia, Bologna. Anno 2018.

- “Treating Depression occurring with Comorbid Medical conditions” Masterclass outcomes and clinical strategies for a successful treatment of depression. Palermo 2018. Accreditamento ECM: accreditato con n.7 crediti         formativi per Medici Chirurghi specialisti in Psichiatria, Neurologia, Psicoterapia

- “Master Train The Trainer (TTT) Società Italiana Medicina Generale (SIMG): Terapie farmacologiche per la depressione. I farmaci antidepressivi nella pratica clinica di Medicina”. Generale Firenze 9-10 Ottobre 2018

- “Pharmacological treatment in patients with comorbid medical illness” and “The art and the science of combining medications”. Treating Schizophrenia in 2018 and forward: Long Acting Antipsychotics as a strategy for a       successful outcome, Cairo, October 25th - 26th, 2018.

- Seminario di alta formazione in Psichiatria: Le Psicosi Schizofreniche, dall’acuzie al recupero clinico, funzionale e personale. Azienda Ospedaliero – Universitaria “S. Luigi Gonzaga” Orbassano (TO)

- “Trattamento della psicosi in pazienti con comorbidità medica”. Nuovi strumenti per una psichiatria di precisione: focus sulla schizofrenia. BERTINORO 9 novembre 2018. 

- Advisory Board – Information news insight – Update Trazodone 2018.

-“Trattamento dimensionale delle malattie mentali: Strategie di associazione dei farmaci psicotropi” Italian society of psychopathology (SOPSI) February 2019, Rome.

- “Trattamento psicofarmacologico delle situazioni cliniche complesse: trattamento agitazione psicomotoria nell’intossicazione da sostanze” February 2019, Rome.

- Società Italiana di Medicina Generale - Scuola Di Alta Formazione Progetto “Terapie Farmacologiche Per La Depressione”: i Farmaci Antidepressivi nella Pratica Clinica Di Medicina Generale. 2019 

- Farmacoterapia Dimensionale della Depressione: focus su tollerabilità e relative strategie di personalizzazione (e.g., giovani, anziani, pazienti con comorbilità fisica) 2019

 

 RESEARCH INTERESTS
 
• Pharmacological Treatment of Mood Disorders
• Diagnosis and course of Bipolar Disorder
• Personalized treatment of psychiatric diseases
• Treatment resistant psychiatric disorders
• Psychopharmacology Treatment during Pregnancy and Lactation
• Managing and Treatment of medical comorbidities in patients with severe mental illness
• The role of vitamin D and microbiome in psychiatric diseases
• Co-investigator in several research studies, including phase 3 and phase 4 clinical trials.